Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer
- Resource Type
- Article
- Source
- In
Journal of Controlled Release February 2024 366:204-220 - Subject
- Language
- ISSN
- 0168-3659